Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery

References

• Aisner J, Lee EJ. (1991). Etoposide. Current and future status. Cancer 67:215–9
   PubMed Web of Science ®Google Scholar
• Anderson JM, Shive MS. (2012). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 64:72–82
   Web of Science ®Google Scholar
• Bi R. (2008). Studies on dry powder inhalation of insulin loaded solid lipid nanoparticles. Shandong: Shandong University
   Google Scholar
• Calame W, van der Waals R, Douwes-Idema N, et al. (1988). Antibacterial effect of etoposide in vitro. Antimicrob Agents Chemother 32:1456–7
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–33
   PubMed Web of Science ®Google Scholar
• Diab R, Brillault J, Bardy A, et al. (2012). Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rifampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer: efficiency for ex vivo alveolar macrophage targeting. Int J Pharm 436:833–9
   PubMed Web of Science ®Google Scholar
• Doan T, Couet W, Olivier J. (2011). Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Int J Pharm 414:112–7
   PubMed Web of Science ®Google Scholar
• Gao J. 2005. Study on thymopentin(Tp5) dry powder inhalations for pulmonary delivery and their pharmacodynamics. Shanghai: Second Military Medical University
   Google Scholar
• Giovagnoli S, Blasi P, Schoubben A, et al. (2007). Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. Int J Pharm 333:103–11
   PubMed Web of Science ®Google Scholar
• Han B, Wang HT, Liu HY, et al. (2010). Preparation of pingyangmycin PLGA microspheres and related in vitro/in vivo studies. Int J Pharm 398:130–6
   PubMed Web of Science ®Google Scholar
• Hande KR. (1998). Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 34:1514–21
   PubMed Web of Science ®Google Scholar
• Haznedar S, Dortunc B. (2004). Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm 269:131–40
   PubMed Web of Science ®Google Scholar
• Lam JKW, Liang W, Chan HK. (2012). Pulmonary delivery of therapeutic siRNA. Adv Drug Deliv Rev 64:1–15
   PubMed Web of Science ®Google Scholar
• Lee J, Oh YJ, Lee SK, et al. (2010). Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery. J Control Release 146:61–7
   PubMed Web of Science ®Google Scholar
• Li X, Tang Y, Zhu J. (2010). Progress on dry powder inhalers. Chinese J Pharm 41:219–23
   Google Scholar
• Louey MD, Razia S, Stewart PJ. (2003). Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures. Int J Pharm 252:87–98
   PubMed Web of Science ®Google Scholar
• Nath SD, Son S, Sadiasa A, et al. (2013). Preparation and characterization of PLGA microspheres by the electrospraying method for delivering simvastatin for bone regeneration. Int J Pharm 443:87–94
   PubMed Web of Science ®Google Scholar
• Patlolla R, Vobalaboina V. (2005). Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. J Pharm Sci 94:437–45
   PubMed Web of Science ®Google Scholar
• Patton JS, Bukar J, Nagarajan S. (1999). Inhaled insulin. Adv Drug Deliv Rev 35:235–47
   PubMed Web of Science ®Google Scholar
• Qian WY, Sun DM, Zhu RR, et al. (2012). pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release. Int J Nanomed 7:5781–92
   PubMed Web of Science ®Google Scholar
• Schaefer MJ, Singh J. (2001). Effect of additives on stability of etoposide in PLGA microspheres. Drug Dev Ind Pharm 27:345–50
   PubMed Web of Science ®Google Scholar
• Schaefer MJ, Singh J. (2002). Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres. Biomaterials 23:3465–71
   PubMed Web of Science ®Google Scholar
• Sengupta S, Tyagi P, Velpandian T, et al. (2000). Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies. Pharmacol Res 42:459–64
   PubMed Web of Science ®Google Scholar
• Sham JOH, Zhang Y, Finlay WH, et al. (2004). Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Int J Pharm 269:457–67
   PubMed Web of Science ®Google Scholar
• Silva LFC, Kasten G, de Campos CEM, et al. (2013). Preparation and characterization of quercetin-loaded solid lipid microparticles for pulmonary delivery. Powder Technol 239:183–92
   Web of Science ®Google Scholar
• Sinha VR, Singla AK, Wadhawan S, et al. (2004). Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274:1–33
   PubMed Web of Science ®Google Scholar
• Steckel H, Brandes HG. (2004). A novel spray-drying technique to produce low density particles for pulmonary delivery. Int J Pharm 278:187–95
   PubMed Web of Science ®Google Scholar
• Tamber H, Johansen P, Merkle HP, Gander B. (2005). Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 57:357–76
   PubMed Web of Science ®Google Scholar
• van Meerbeeck JP, Fennell DA, De Ruysscher DK. (2011). Small-cell lung cancer. Lancet 378:1741–55
   PubMed Web of Science ®Google Scholar
• Vanbever R, Mintzes JD, Wang J, et al. (1999). Formulation and physical characterization of large porous particles for inhalation. Pharm Res 16:1735–42
   PubMed Web of Science ®Google Scholar
• White S, Bennett DB, Cheu S, et al. (2005). EXUBERA®: pharmaceutical development of a novel product for pulmonary delivery of insulin. Diabetes Technol Ther 7:896–906
   PubMedGoogle Scholar
• Xu Q, Czernuszka JT. (2008). Controlled release of amoxicillin from hydroxyapatite-coated poly (lactic-co-glycolic acid) microspheres. J Control Release 127:146–53
   PubMed Web of Science ®Google Scholar
• Yadav KS, Chuttani K, Mishra AK, Sawant KK. (2010). Long circulating nanoparticles of etoposide using PLGA-MPEG and PLGA-pluronic block copolymers: characterization, drug-release, blood-clearance, and biodistribution studies. Drug Dev Res 71:228–39
   Web of Science ®Google Scholar
• Yang Y, Bajaj N, Xu P, et al. (2009). Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials 30:1947–53
   PubMed Web of Science ®Google Scholar
• Yen SY, Sung KC, Wang JJ, et al. (2001). Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies. Int J Pharm 220:91–9
   PubMed Web of Science ®Google Scholar
• Zhang Z, Bi X, Li H, et al. (2011). Enhanced targeting efficiency of PLGA microspheres loaded with Lornoxicam for intra-articular administration. Drug Deliv 18:536–44
   PubMed Web of Science ®Google Scholar
• Zhang Z, Huang G. (2012). Intra-articular lornoxicam loaded PLGA microspheres: enhanced therapeutic efficiency and decreased systemic toxicity in the treatment of osteoarthritis. Drug Deliv 19:255–63
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Burgess DJ. (2007). Effect of acidic pH on PLGA microsphere degradation and release. J Control Release 122:338–44
   PubMed Web of Science ®Google Scholar